Matsui Kiyoshi Department
Specialty Division
, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome. 2013/11
2.
Original article
Relationship between YKL-40 and Pulmonary Arterial Hypertension in Systemic Sclerosis. 2018/05
3.
Original article
Predictive factors for structural remission using abatacept: Results from the ABROAD study. 2019/05
4.
Original article
Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05
5.
Original article
Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05
6.
Case report
Efficacy of using trimethoprim-sulfamethoxazole prophylaxis in an adult patient with autoimmune neutropenia. 2019/09
7.
Original article
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study. 2019/09
8.
Original article
Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis. 2019/09
9.
Original article
Delayed onset of metronidazole-induced encephalopathy in a patient with systemic sclerosis accompanied by intestinal pseudo-obstruction. 2020/01
10.
Original article
Recurrent myocardial infarction associated with vasculo-Behçet's disease: a case report. 2020/07
11.
Original article
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study. 2020/09
12.
Original article
Functional Evaluation of Anti-TNF-α Affibody Molecules in Biochemical Detection and Inhibition to Signalling Pathways of a Synovial Cell. 2021
13.
Original article
Evaluation of changes in oral health-related quality of life over time in patients with Sjögren's syndrome. 2021/05
14.
Introduction
Cell-Free DNA in rheumatoid arthritis. 2021/08
15.
Original article
Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. 2022/01
16.
Original article
Construction of HGF-Displaying Yeast by Cell Surface Engineering. 2022/07
17.
Original article
A Nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan. 2022/08
18.
Original article
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS). 2022/08
19.
Original article
Effectiveness of apremilast against Behçet's disease-associated mucocutaneous and joint involvement confirmed through switching from adalimumab. 2022/09
20.
Original article
Serum B cell activating factor(BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis. 2022/12
21.
Original article
The role of pain catastrophizing in pain perception among patients with rheumatoid arthritis without clinical signs of inflammation. 2023/02
22.
Original article
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study. 2023/03
23.
Case report
Cytomegalovirus-associated splenic infarction in rheumatoid arthritis. 2023/03
24.
Original article
Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study. 2023/04
25.
Original article
Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis. 2023/07
26.
Case report
nfarctus Splénique associé au cytomegalovirus dans la polyarthrite rheumatoïde. 2023/10
Abatacept treatment suppresses T cell activation in anti-cyclic citrullinated peptide antibody(ACPA) positive RA patients but not in ACPA negative ra patients. (Poster presentation,General Lecture) 2013/06/15
2.
Changes in cytokine profiles in rheumatoid arthritis patients during abatacept treatment. (Poster presentation,General Lecture) 2013/06/15
3.
Effect of abatacept on bone homeostasis and osteopontin in rheumatoid arthritis. (Poster presentation,General Lecture) 2013/06/15
4.
The perturbation of CD8-positive T-cell repertoire in peripheral blood is characteristic for IgG4-related disease. (Poster presentation) 2013/10/10
5.
Higher titer of anti-citrullinated protein antibodies in biologic-naïve rheumatoid arthritis patients are candidate biomarkers to predict sensitivity leadiong to clinicalremission with abatacept; data from the abroad study. (Poster presentation,General Lecture) 2013/10/27
6.
Treatment responses and their predictors of abatacept in biologic naïve patients with rheumatoid arthritis; data form abroad study. (Poster presentation,General Lecture) 2013/10/28
7.
Soluble interleukin-2 receptor levels and the CD4/CD8 ratio as predictors of the efficacy of abatacept in biologics-naïve rheumatoid arthritis patients. (Poster presentation,General Lecture) 2013/10/29
8.
Systemic Immune-inflammation index in rheumatoid arthritis patients:relation to disease activity. (Poster presentation,General Lecture) 2019/06/13
9.
Circulating cell free DNA released from eosinophils is a practical biomarker in patients with eosinophilic granulomatosis with polyangiitis. (Poster presentation,General Lecture) 2019/11/11
10.
Evaluation of changes in oral health-related quality of life over time in patients with Sjögren’syndrome. (Poster presentation,General Lecture) 2019/11/11
11.
Relationship between YKL-40, VEGF, and IL-5 in borderline mPAP and pulmonary hypertension in systemic sclerosis. (Poster presentation,General Lecture) 2019/11/11
12.
A usability survey of wrist mounted disposable heat pad on raynaud’s phenomenon in patients with connective tissue diseases. (Poster presentation,General Lecture) 2020/07/03
13.
The baseline soluble GP130 is associated with the response of rheumatoid arthritis patients to sarilmab. (Poster presentation,General Lecture) 2020/07/03
14.
Circulating cell free DNA as a biomarker in Eosinophilic granulomatosis with polyangiitis. (Web announcement,Symposium/Workshop/Panel Discussion) 2020/09/17
15.
Pregnancy-related hemophagocytic lymphohistiocytosis: a report of three cases with assessing cytokines profile. (Web announcement,General Lecture) 2020/09/17
16.
New-onset pulmonary sarcoidosis under tocilizumab treatment for rheumatoid arthritis:Case report and
literature review. 2020.10 (WEB) (10/24-9) (Web announcement,General Lecture) 2020/10/24
17.
Wrist mounted disposable heat pad is a highly practical heating method for connective tissue diseases patients presenting with Raynaud’s Phenomenon. 22nd Asia-Pacific League of Associations for Rheumatology
Virtual Congress (APLAR2020) (Web announcement,General Lecture) 2020/10/24
18.
Increased levels of serum wisteria floribunda agglutininpositive Mac-2 binding protein in rheumatic diseases including SLE. (Newspaper announcement) 2021/06/02
19.
Successful treatment of checkpoint inhibitor-induced arthritis with the IL-6 receptor inhibitor Sarilumab. (Poster presentation,General Lecture) 2021/08/28
20.
Plasma cell-free DNA is a useful biomarker for tocilizumab therapy in rheumatoid arthritis. (Poster presentation,General Lecture) 2021/11/08
21.
Neutrophil count reduction 1month after initiating sarilumab and baseline serum soluble gp130 levels can independently predict clinical remission within 3 month in rheumatoid arthritis patients. (Newspaper announcement) 2022/06/01
22.
Sodium bicarbonate mouth rinse is a useful self-care method for dry mouth in patients with sjögren’syndrome. (Newspaper announcement) 2022/06/01
23.
The baseline serum soluble TNF receptor level are associated with the response of rheumatoid arthritis
patients to JAKinibs. (Newspaper announcement) 2022/06/01
24.
Continued positivity in serum MMP-3 after normalization of CRP predicts future joint destruction in rheumatoid arthritis patients treated with MTX (Poster presentation,General Lecture) 2022/10/09
25.
YKL-40-mediated Inflammatory pathogenesis common to polymyositis/dermatomyositis. (Poster presentation,General Lecture) 2022/10/14
26.
Association between disease activity and changes in fibrosis-4 index level in patients with rheumatoid arthritis treated with methotrexate for a short period. (Newspaper announcement) 2023/05/31
27.
Predictive factors for the flare of patients with rheumatoid arthritis (RA) in ultrasound remission(US-R). (Poster presentation,General Lecture) 2023/06/01